Evaluation of Dry Eyes
Customize your policy alerts
Sign up for mutualofomaha Policy AHS - G2138 - Evaluation of Dry Eyes alerts
Get alerted when Policy AHS - G2138 - Evaluation of Dry Eyes changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage for laboratory and point-of-care testing used to evaluate, assess severity of, or monitor dry eye disease. Tear osmolarity testing is covered in specified clinical situations, while MMP-9, lactoferrin, IgE, and other testing not specifically addressed do not meet coverage criteria.
The policy was reviewed and updated, including updates to the background, guidelines and recommendations, and scientific references.
Coverage criterion CC1 was edited for clarity and consistency.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.